期刊文献+

慢性疼痛并发抑郁症和焦虑症的治疗研究 被引量:4

Therapy Research on Chronic Pain Complicated with Depression and Anxiety
下载PDF
导出
摘要 目的:探讨中西医结合治疗慢性疼痛患者并发抑郁、焦虑症的临床疗效。方法:将122例患者按随机数字表法分为治疗组和对照组。治疗组61例依据中医辨证口服中药治疗,对照组61例使用盐酸氟哌噻吨片治疗。于治疗前、治疗8周后,采用疼痛视觉模拟评分(VAS)评定患者的疾病程度,使用17项汉密尔顿抑郁量表(HAMD)和汉密尔顿焦虑量表(HAMA)分别评定患者的抑郁和焦虑状况。结果:治疗前两组患者疼痛程度差异、HAMD和HAMA评分无统计学意义(P>0.05);治疗8周后疼痛程度差异、HAMD和HAMA评分有统计学意义(P<0.05)。结论:慢性疼痛患者并发的抑郁和焦虑症状中医药治疗效果好,不良反应小。 Objective: To study the effect of Chinese and western medicine treatment of chronic pain patients complicated with depression and anxiety. Methods :122 patients were divided into the treatment group and the control group. The treatment group of 61 cases were given pure Chinese medicine, and the control group of 61 cases were treated with Deanxit. Before and 8 weeks after treatment,visual an- alogue scale (VAS) was used to assess the degree of disease, and the Hamilton depression rating scale (HAMD 17 items) and Hamil- ton anxiety scale (HAMA) were used to assess the patients' depression and anxiety respectively. Results :The pain intensity difference of two groups patients before treatment,Hamilton depression rating scale (HAMD) and Hamilton anxiety scale (HAMA) score had no statistical significance (P 〉 0. 05 ) ;The pain intensity difference of the two groups after treatment of 8 weeks, Hamilton depression rating scale (HAMD) and Hamilton anxiety scale (HAMA) score were statistically significant ( P 〈 0.05 ). Conclusion : The effect of chronic pain in hospital patients complicated with depression and anxiety symptoms treated by traditional Chinese medicine is good, and the side effect is small.
出处 《中医学报》 CAS 2013年第12期1905-1906,共2页 Acta Chinese Medicine
基金 郑州市科技攻关项目(编号:112PPTSF319-6)
关键词 慢性疼痛 抑郁症 焦虑症 丹栀逍遥散 半夏厚朴汤 归脾汤 滋水清肝饮 盐酸氟哌噻吨片 chronic pain depression anxiety danzhi xiaoyao power banxia houpu decoction guipi decoction zishui qinggan decoction deanxit
  • 相关文献

参考文献7

二级参考文献59

  • 1徐维安,沈宣,李建新,杨裕芳,俞惠兰,沈志琴,谢关宝,金卫平.黛安神对120例慢性精神分裂症情感淡漠的影响[J].中国民康医学,1999,0(2):16-18. 被引量:3
  • 2谢珍.甘麦大枣汤合归脾汤加减治疗更年期抑郁症57例疗效观察[J].新中医,2004,36(10):26-27. 被引量:29
  • 3NESTLER E J, et al. Neurobiology of depression[J]. Neuron, 2002,34(1) : 13-25.
  • 4RESSLER K J, MAYBERG H S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic[J]. Nat Neurosci, 2007,10 (9) : 1116-1124.
  • 5aan het ROT M, MATHEW S J, CHARNEY D S. Neurobiological mechanisms in major depressive disorder[J]. CMAJ, 2009,180(3) : 305-313.
  • 6DREVETS W C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders[J]. Curr Opin Neurobiol, 2001, 11 (2) ; 240-249.
  • 7MAYBERG H S. Positron emission tomography imaging in depression: a neural systems perspective[J]. Neuroimaging Clin N Am, 2003,13(4) :805-815.
  • 8RAJKOWSKA G. Depression.. what we can learn from postmortem studies[J]. Neuroscientist, 2003,9(4) : 273-284.
  • 9BERTON O, NESTLER E J. New approaches to antidepressant drug discovery: beyond monoamines[J]. Nat Rev Neurosci, 2006,7(2): 137-151.
  • 10TRIVEDI M H, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR * D: implications for clinical practice[J]. Am J Psychiatry, 2006, 163(1): 28-40.

共引文献60

同被引文献47

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部